Therapy of diseases of the eye, the inner ear and the central nervous system
US7488749B2 · kind B2 · utility
2Cited by
3References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 12, 2003 |
| Grant date | Feb 10, 2009 |
| Priority date | — |
| Expiry date | Dec 22, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y114/18001
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 5,6-dihydroxyindole (DHI), 5,6-dihydroxyindole-2-carboxylic acid (DHICA) and/or 5-S-cysteinyldopa (CD) as medicaments, as well as their use, and the use of tyrosinase for the preparation of a medicament for prophylaxis or therapy of diseases induced by oxidative stress. Furthermore, the present invention relates to the use of gene therapy vectors comprising a tyrosinase gene. Further, the present invention relates to cells modified by a tyrosinase gene.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.